Combined use of WT1 and flow cytometry monitoring can promote sensitivity of predicting relapse after allogeneic HSCT without affecting specificity
Published 2013 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Combined use of WT1 and flow cytometry monitoring can promote sensitivity of predicting relapse after allogeneic HSCT without affecting specificity
Authors
Keywords
Allogeneic hematopoietic stem cell transplantation, Wilms’ tumor gene 1, Relapse, Minimal residual diseases, Flow cytometry
Journal
ANNALS OF HEMATOLOGY
Volume 92, Issue 8, Pages 1111-1119
Publisher
Springer Nature
Online
2013-05-16
DOI
10.1007/s00277-013-1733-1
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Has MRD monitoring superseded other prognostic factors in adult ALL?
- (2012) M. Bruggemann et al. BLOOD
- CD86 is expressed on murine hematopoietic stem cells and denotes lymphopoietic potential
- (2012) T. Shimazu et al. BLOOD
- Risk stratification-directed donor lymphocyte infusion could reduce relapse of standard-risk acute leukemia patients after allogeneic hematopoietic stem cell transplantation
- (2012) C.-H. Yan et al. BLOOD
- Retrospective analysis of prognostic factors for angioimmunoblastic T-cell lymphoma: a multicenter cooperative study in Japan
- (2012) T. Tokunaga et al. BLOOD
- Prognostic and therapeutic implications of minimal residual disease at the time of transplantation in acute leukemia
- (2012) S A Buckley et al. BONE MARROW TRANSPLANTATION
- Survival, prognostic factors and rates of leukemic transformation in 381 untreated patients with MDS and del(5q): A multicenter study
- (2012) U Germing et al. LEUKEMIA
- Case 38-2012
- (2012) John H. Stone et al. NEW ENGLAND JOURNAL OF MEDICINE
- Should Minimal Residual Disease Monitoring in Acute Lymphoblastic Leukemia be Standard of Care?
- (2012) Dario Campana Current Hematologic Malignancy Reports
- Monitoring MRD with flow cytometry: an effective method to predict relapse for ALL patients after allogeneic hematopoietic stem cell transplantation
- (2011) Xiao-Su Zhao et al. ANNALS OF HEMATOLOGY
- Prognostic and therapeutic implications of minimal residual disease detection in acute myeloid leukemia
- (2011) F. Buccisano et al. BLOOD
- Wilms’ tumor gene 1 expression: an independent acute leukemia prognostic indicator following allogeneic hematopoietic SCT
- (2011) X-S Zhao et al. BONE MARROW TRANSPLANTATION
- Impact of Pretransplantation Minimal Residual Disease, As Detected by Multiparametric Flow Cytometry, on Outcome of Myeloablative Hematopoietic Cell Transplantation for Acute Myeloid Leukemia
- (2011) Roland B. Walter et al. JOURNAL OF CLINICAL ONCOLOGY
- Minimal Residual Disease Diagnostics and Chimerism in the Post-Transplant Period in Acute Myeloid Leukemia
- (2011) Ulrike Bacher et al. TheScientificWorldJOURNAL
- Refinement of cytogenetic classification in acute myeloid leukemia: determination of prognostic significance of rare recurring chromosomal abnormalities among 5876 younger adult patients treated in the United Kingdom Medical Research Council trials
- (2010) D. Grimwade et al. BLOOD
- THE SIGNIFICANCE OF DETECTING WT1 EXPRESSION IN CHILDHOOD ACUTE LEUKEMIAS
- (2010) Shao-Yan Hu et al. PEDIATRIC HEMATOLOGY AND ONCOLOGY
- CLINICAL ANALYSIS AND OPTIMIZATION OF POST-REMISSION THERAPY FOR ACUTE MYELOID LEUKEMIA PATIENTS WITH MINIMAL RESIDUAL DISEASE AS DETERMINED BY FLOW CYTOMETRY
- (2010) Daichi Inoue et al. Mediterranean Journal of Hematology and Infectious Diseases
- Wilms’ tumor gene 1 (WT1) expression in subtypes of acute lymphoblastic leukemia (ALL) of adults and impact on clinical outcome
- (2009) Antonia Busse et al. ANNALS OF HEMATOLOGY
- HighWT1gene expression before haematopoietic stem cell transplant in children with acute myeloid leukaemia predicts poor event-free survival
- (2009) David A. Jacobsohn et al. BRITISH JOURNAL OF HAEMATOLOGY
- Clinical significance of minimal residual disease in childhood acute lymphoblastic leukemia and its relationship to other prognostic factors: a Children's Oncology Group study
- (2008) M. J. Borowitz et al. BLOOD
- Wilms tumour gene 1 overexpression in bone marrow as a marker for minimal residual disease in acute myeloid leukaemia
- (2008) Mauri M. Hämäläinen et al. EUROPEAN JOURNAL OF HAEMATOLOGY
- Modified Donor Lymphocyte Infusion after HLA-Mismatched/Haploidentical T Cell-replete Hematopoietic Stem Cell Transplantation for Prophylaxis of Relapse of Leukemia in Patients with Advanced Leukemia
- (2008) Xiao-Jun Huang et al. JOURNAL OF CLINICAL IMMUNOLOGY
- Modified Donor Lymphocyte Infusion (DLI) for the Prophylaxis of Leukemia Relapse after Hematopoietic Stem Cell Transplantation in Patients with Advanced Leukemia—Feasibility and Safety Study
- (2008) Xiao-Jun Huang et al. JOURNAL OF CLINICAL IMMUNOLOGY
- Expression patterns of WT1 and PRAME in acute myeloid leukemia patients and their usefulness for monitoring minimal residual disease
- (2008) YaZhen Qin et al. LEUKEMIA RESEARCH
Find Funding. Review Successful Grants.
Explore over 25,000 new funding opportunities and over 6,000,000 successful grants.
ExploreFind the ideal target journal for your manuscript
Explore over 38,000 international journals covering a vast array of academic fields.
Search